Calithera Biosciences | CT ORDER: Confidential Treatment Order
Jun 12, 2023 20:53 ET
Calithera Biosciences | DEFM14A: Definitive proxy statement relating to merger or acquisition
Jun 5, 2023 17:16 ET
Calithera Biosciences | PREM14A: Preliminary proxy statements relating to merger or acquisition
May 26, 2023 16:26 ET
Calithera Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(0.0%),Takeda Ventures, Inc(0.0%)
May 26, 2023 07:08 ET
Calithera Biosciences | 4: Statement of changes in beneficial ownership of securities-Other TAKEDA PHARMACEUTICAL CO LTD
May 26, 2023 07:08 ET
Calithera Biosciences | DEFA14A: Others
May 19, 2023 20:50 ET
Calithera Biosciences: FY2022 Annual Report
10-K | Calithera Biosciences, Inc. (0001496671) (Filer)
Mar 30, 2023 17:38 ET
Calithera Biosciences | EFFECT: Others
Mar 20, 2023 00:15 ET
Calithera Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 14, 2023 16:15 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:13 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:12 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:11 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:10 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:09 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:08 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:07 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:06 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:04 ET
Calithera Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 14, 2023 16:02 ET
Calithera Biosciences | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 3, 2023 10:45 ET
No Data
No Data